Mirati (MRTX) Q4 Earnings and Sales Fall Short of Estimates
1/3 13:52
Mirati Therapeutics MRTX reported fourth-quarter loss of $3.72 per share, which was wider than the Zacks Consensus Estimate of a loss of $3.01 as well as the year-ago loss of $2.08 per share....